US Patent Issued to BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM on Oct. 27 for "Human application of engineered chimeric antigen receptor (CAR) T-cells" (Texas Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,317, issued on Oct. 27, was assigned to BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (Austin, Texas).

"Human application of engineered chimeric antigen receptor (CAR) T-cells" was invented by Laurence J.N. Cooper (Houston), Hiroki Torikai (Houston), Ling Zhang (Houston), Helen Huls (Houston), Feng Wang-Johanning (Bastrop, Texas), Lenka Hurton (Houston), Simon Olivares (Houston) and Janani Krishnamurthy (Houston).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention concerns methods and compositions for immunotherapy employing a modified T cell comprising a chimeric antigen receptor (CAR). In particular aspects, CAR-expressing T-cel...